Replies to post #1960 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>is an inhaled rhAAT a possibiltiy for GTC…?<

I doubt that GTC would embark on that kind of program. GTC’s business plan is to make drugs using its transgenics platform that are biosimilar to existing drugs. GTC’s business plan does not entail programs to develop brand new drugs or new delivery mechanisms.